Artonin E mediates MCL1 down-regulation and sensitizes lung cancer cells to anoikis

Ekkarat Wongpankam1, Preedakorn Chunhacha, Varisa Pongrakhananon

  • 1Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulakongkorn University, Phatumwan, Bangkok, 10330 Thailand.

Anticancer Research
|December 11, 2012
PubMed
Abstract

Insights

Artonin E (AE) enhances anoikis, or detachment-induced apoptosis, in lung cancer cells. This compound offers a potential new therapeutic strategy by sensitizing cancer cells to anoikis, thereby inhibiting metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Anoikis, a crucial process inhibiting cancer metastasis, is often resisted by lung cancer cells.
  • Lung cancer's resistance to anoikis contributes to high metastasis rates and mortality.
  • Artonin E (AE) is investigated for its potential to sensitize lung cancer cells to anoikis.

Purpose of the Study:

  • To investigate the anoikis-sensitizing effect of Artonin E (AE) on human lung cancer cells.
  • To explore the molecular mechanisms underlying AE's impact on anoikis.
  • To evaluate AE as a potential therapeutic agent for lung cancer.

Main Methods:

  • Artonin E (AE) was extracted from Artocarpus gomezianus bark.
  • Anoikis sensitization was assessed in H460, A549, and H292 lung cancer cell lines.
  • Protein levels of anoikis-related factors were analyzed via western blot; cell viability was measured using the XTT assay.

Main Results:

  • AE demonstrated a dose-dependent enhancement of anoikis in H460 lung cancer cells.
  • AE sensitized cells by down-regulating myeloid leukemia cell sequence-1 (MCL1), an anti-apoptotic protein.
  • Significant anoikis sensitization by AE was observed across H460, A549, and H292 cell lines, with no major impact on BCL2 or BAX.

Conclusions:

  • Artonin E exhibits a novel activity in promoting lung cancer cell anoikis.
  • AE's ability to sensitize lung cancer cells to anoikis presents a potential new therapeutic strategy.
  • This research may pave the way for novel treatments targeting lung cancer metastasis.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...